Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
Price and Volume
Detailed Quote| Volume | 1,855,940 |
| Open | 109.62 |
| Bid (Size) | 108.40 (100) |
| Ask (Size) | 110.99 (100) |
| Prev. Close | 109.86 |
| Today's Range | 107.68 - 109.87 |
| 52wk Range | 61.23 - 116.84 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
7.3% below 52-week high
108.31
61.2352W Low
116.8452W High
1 Week
5.4% below 1-week high
106.651W Low
114.521W High
Halozyme Therapeutics, Inc. - Common Stock (HALO) traded between $61.23 and $116.84 over the past 52 weeks and last traded at $108.31, 7.3% below its 52-week high. Over the past week it ranged between $106.65 and $114.52.
Past 12 Months
1W
-$4.58
1M
-$1.88
3M
+$27.53
6M
+$45.21
YTD
+$38.00
1Y
+$41.34
HALO was +61.7% over the past year, +71.6% over six months, +54.0% year to date, -4.1% in the last week.
12 Months vs Market
HALO
+61.7%
DIA
+9.7%
SPY
+15.4%
QQQ
+24.4%
IWM
+14.8%
Over the past 12 months HALO returned +61.7% versus DIA (Dow) +9.7%, SPY (S&P 500) +15.4%, QQQ (Nasdaq 100) +24.4% and IWM (Russell 2000) +14.8%.
Volume & Liquidity
0.84× 3-mo avg
Today 1,855,940
3-mo avg 2.2M
1W
2.7M
1M
2.6M
3M
2.2M
6M
2.0M
YTD
1.9M
1Y
2.0M
HALO most recently traded 1,855,940 shares against a 3-month average daily volume of 2.2M.
More News
Read More
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
1 Cash-Producing Stock to Target This Week and 2 We Question
September 22, 2026
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
August 31, 2026
3 Market-Beating Stocks for Long-Term Investors
August 28, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
August 24, 2026
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
1 Profitable Stock to Research Further and 2 We Ignore
August 07, 2026
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
August 04, 2026
3 Growth Stocks Set to Flourish
August 03, 2026
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
July 24, 2026
1 Value Stock Worth Investigating and 2 Facing Headwinds
July 15, 2026
2 Reasons to Like HALO and 1 to Stay Skeptical
July 10, 2026
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 108.31
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/05/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 15.42B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 15B shares outstanding.